Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
oral drug delivery
Biotech
OrbiMed-backed Pinnacle adds $89M for oral peptides
The funds will fuel Pinnacle's preclinical pipeline through early clinical testing, with a focus on immunology and cardiometabolic indications.
Darren Incorvaia
Mar 26, 2026 10:29am
Novo Nordisk inks $2.1B oral drug delivery pact
Feb 25, 2026 8:00am
Novo expands pivotal program after amycretin shines in diabetes
Nov 25, 2025 7:44am
GSK unveils pivotal data on oral antibiotic ahead of FDA filing
Oct 21, 2025 10:55am
Lilly pads oral GLP-1 case with pair of phase 3 diabetes wins
Oct 15, 2025 9:48am
Lilly rounds out orforglipron data ahead of obesity filings
Sep 17, 2025 9:00am
